Omega Diagnostics Group PLC Hardman Research: Food intolerance driving growth
November 29 2016 - 2:15AM
RNS Non-Regulatory
TIDMODX
Omega Diagnostics Group PLC
29 November 2016
Hardman Research: Food intolerance driving growth
Food intolerance driving growth: Omega Diagnostics Group has an
established core business providing high quality in vitro
diagnostic tests within three core areas of competence - Food
Intolerance, Allergy & Autoimmune, Infectious Disease - that
are sold in over 100 countries. The group offers steady low
single-digit growth which is profitable and cash generative.
Investment in new products has seen the launch of a new panel of
automated allergy tests and progress on Visitect for diagnosis of
HIV. Given Omega's established position, the Board sees
opportunities for an accelerated growth strategy.
Please click here for the full report:
http://www.hardmanandco.com/docs/default-source/company-docs/omega-diagnostics-group-plc-documents/29.11.16-food-intolerance-driving-growth.pdf
To contact us: Analysts:
Hardman & Co Dr Martin Hall mh@hardmanandco.com
11/12 Tokenhouse Dr Dorothea Hill dmh@hardmanandco.com
Yard Dr Gregoire Pave gp@hardmanabdco.com
London Telephone: +44 20 7929 3399
EC2R 7AS Follow us on Twitter @HardmanandCo
www.hardmanandco.com
About Hardman & Co: For the past 20 years Hardman has been
producing specialist research designed to improve investors'
understanding of companies, sectors, industries and investment
securities. Our analysts are highly experienced in their sectors,
and have often been highly rated by professional investors for
their knowledge. Our focus is to raise companies' profiles across
the UK and abroad with outstanding research, investor engagement
programmes and advisory services. Some of our notes have been
commissioned by the company which is the subject of the note; this
is clearly stated in the disclaimer where this is the case.
Hardman Research Ltd, trading as Hardman & Co, is an
appointed representative of Capital Markets Strategy Ltd and is
authorised and regulated by the Financial Conduct Authority; our
FCA registration number is 600843. Hardman Research Ltd is
registered at Companies House with number 8256259.
Our research is provided for the use of the professional
investment community, market counterparties and sophisticated and
high net worth investors as defined in the rules of the regulatory
bodies. It is not intended to be made available to unsophisticated
retail investors. Anyone who is unsure of their categorisation
should consult their professional advisors. This research is
neither an offer, nor a solicitation, to buy or sell any security.
Please read the note for the full disclaimer.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAEAXFPALDKFFF
(END) Dow Jones Newswires
November 29, 2016 02:15 ET (07:15 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024